Fair Value Measurements (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Unpaid Principal, Fair Value and Impact of Changes in Fair Value on Financial Instruments |
The table below shows the unpaid principal and fair value of the financial instruments carried at fair value with changes in fair value reflected in earnings under the fair value option election as of June 30, 2026 and December 31, 2025, respectively: | | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | (dollars in thousands) | | Unpaid Principal/ Notional | Fair Value | | Unpaid Principal/ Notional | Fair Value | | Assets: | | | | | | | Non-Agency RMBS | | | | | | | Senior | $ | — | | $ | — | | | $ | — | | $ | — | | | Subordinated | 313,240 | | 148,232 | | | 346,640 | | 174,575 | | | Interest-only | 2,327,935 | | 68,178 | | | 2,428,976 | | 78,961 | | | Agency RMBS | | | | | | | Pass-through | 5,041,259 | | 5,014,494 | | | 3,096,299 | | 3,081,573 | | | CMO | 231,192 | | 232,653 | | | 330,871 | | 331,909 | | | Interest-only | — | | — | | | 367,866 | | 14,867 | | | Agency CMBS | | | | | | | ACMBS bond | 17,905 | | 17,414 | | | N/A | N/A | | Project loans | — | | — | | | 39,693 | | 32,539 | | | Interest-only | — | | — | | | 123,375 | | 2,597 | | | Loans held for investment, at fair value | 8,141,676 | | 7,890,790 | | | 9,988,601 | | 9,803,615 | | | Loans held for sale, at fair value | 1,103,428 | | 1,126,461 | | | 871,787 | | 896,117 | | | Interests in MSR financing receivables | 34,472 | | 35,471 | | | 40,886 | | 37,294 | | Liabilities (1): | | | | | | | Secured financing agreements, at fair value | 293,052 | | 283,984 | | | 305,817 | | 298,663 | | | Securitized debt at fair value, collateralized by Loans held for investment | 5,773,024 | | 5,408,277 | | | 7,081,957 | | 6,721,302 | | (1) The Company recorded $4 million unrealized gain and $2 million unrealized loss for contingent earn-out liability as of June 30, 2026 and December 31, 2025, respectively. The contingent earn-out liability balance is included in Accounts payable and other liabilities on the Company’s Consolidated Statements of Financial Condition.
The table below shows the impact of change in fair value on each of the financial instruments carried at fair value with changes in fair value reflected in earnings under the fair value option election in the Consolidated Statements of Operations for the quarters and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | For the Quarters Ended | | For the Six Months Ended | | June 30, 2026 | June 30, 2025 | | June 30, 2026 | June 30, 2025 | | (dollars in thousands) | | (dollars in thousands) | | Gain/(Loss) on Change in Fair Value | | Gain/(Loss) on Change in Fair Value | | Assets: | | | | | | | Non-Agency RMBS | | | | | | | Senior | $ | — | | $ | 1,057 | | | $ | — | | $ | 1,284 | | | Subordinated | (257) | | 40 | | | (540) | | 1,323 | | | Interest-only | (4,825) | | 2,895 | | | (6,604) | | 12,730 | | | Agency RMBS | | | | | | | Pass-through | (5,519) | | 20,736 | | | (42,046) | | 20,005 | | | CMO | (61) | | 394 | | | 396 | | 1,861 | | | Interest-only | 3,864 | | 294 | | | 3,770 | | (310) | | | Agency CMBS | | | | | | | ACMBS bond | (86) | | N/A | | (86) | | N/A | | Project loans | 4,796 | | 1,884 | | | 7,756 | | 2,523 | | | Interest-only | 674 | | (296) | | | 697 | | 73 | | | Loans held for investment, at fair value | (58,799) | | 57,139 | | | (100,952) | | 209,070 | | | Loans held for sale, at fair value | 6,986 | | N/A | | (1,298) | | N/A | | Interests in MSR financing receivables | — | | N/A | | 4,592 | | N/A | Liabilities (1): | | | | | | | Secured financing agreements, at fair value | 543 | | (3,285) | | | 1,914 | | (9,459) | | | Securitized debt at fair value, collateralized by Loans held for investment | 14,740 | | (73,557) | | | 45,841 | | (101,804) | | (1) The Company recorded $860 thousand unrealized loss and $4 million unrealized gain for contingent earn-out liability during the quarter and six months ended June 30, 2026, respectively. The Company recorded $330 thousand and $1 million unrealized losses for contingent earn-out liability during the quarters and six months ended June 30, 2025, respectively. The contingent earn-out liability balance is included in Accounts payable and other liabilities on the Company’s Consolidated Statements of Financial Condition.
|
| Summary of Unobservable Inputs Assumptions |
The table below presents information about the significant unobservable inputs used for recurring fair value measurements for Level 3 Interests in MSR financing receivables. The table does not give effect to the Company’s risk management practices that might offset risks inherent in these Level 3 investments. | | | | | | | | | | | | | | | | | June 30, 2026 | | Discount Rate | Prepayment Rate | | | Range | Weighted Average | Range | Weighted Average | | | Interests in MSR financing receivables | 8% - 12% | 8.6% | 0% - 51% | 7.1% | |
| | | | | | | | | | | | | | | | | December 31, 2025 | | Discount Rate | Prepayment Rate | | | Range | Weighted Average | Range | Weighted Average | | | Interests in MSR financing receivables | 9% - 12% | 8.9% | 3% - 45% | 7.3% | |
A summary of the significant inputs used to estimate the fair value of Level 3 Non-Agency RMBS held for investment at fair value as of June 30, 2026 and December 31, 2025 follows. The weighted average discount rates are based on fair value. | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | Significant Inputs | | Discount Rate | Prepay Rate | CDR | Loss Severity | | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | | Non-Agency RMBS | | | | | | | | | | Senior | 6% - 15% | 6.3% | 6% - 20% | 6.7% | 0% - 16% | 1.1% | 26% - 87% | 29.8% | | Subordinated | 6% - 15% | 8.4% | 6% - 30% | 9.1% | 0% - 3% | 0.7% | 20% - 50% | 30.2% | | Interest-only | 9% - 100% | 10.0% | 6% - 22% | 7.1% | 0% - 9% | 0.8% | 0% - 86% | 27.0% |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | Significant Inputs | | Discount Rate | Prepay Rate | CDR | Loss Severity | | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | | Non-Agency RMBS | | | | | | | | | | Senior | 5% - 20% | 6.1% | 6% - 25% | 6.8% | 0% - 7% | 1.2% | 26% - 54% | 29.0% | | Subordinated | 0% - 15% | 8.6% | 6% - 24% | 9.1% | 0% - 3% | 0.8% | 20% - 50% | 32.0% | | Interest-only | 9% - 100% | 9.9% | 6% - 25% | 7.0% | 0% - 13% | 0.8% | 0% - 84% | 28.4% |
A summary of the significant inputs used to estimate the fair value of securitized debt at fair value, collateralized by Loans held for investment, as of June 30, 2026 and December 31, 2025 follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | Significant Inputs | | Discount Rate | Prepay Rate | CDR | Loss Severity | | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | | Securitized debt at fair value, collateralized by Loans held for investment | 5% - 8% | 5.9% | 6% - 20% | 8.4% | 0% - 4% | 0.5% | 20% - 45% | 33.2% |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | Significant Inputs | | Discount Rate | Prepay Rate | CDR | Loss Severity | | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | Range | Weighted Average | | Securitized debt at fair value, collateralized by Loans held for investment | 4% - 8% | 5.4% | 6% - 20% | 8.1% | 0% - 4% | 0.5% | 20% - 50% | 33.9% |
A summary of the significant factors used to estimate the fair value of Loans held for investment collateralized primarily by seasoned reperforming residential mortgages at fair value as of June 30, 2026 and December 31, 2025 is as follows: | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | Factor: | | | | | Coupon | | | | | Base Rate | 5.8 | % | | 5.5 | % | | Actual | 5.8 | % | | 5.9 | % | | | | | | FICO | | | | | Base Rate | 640 | | 640 | | Actual | 668 | | 665 | | | | | | Loan-to-value (LTV) | | | | | Base Rate | 86 | % | | 86 | % | | Actual | 77 | % | | 78 | % | | | | | | Loan Characteristics: | | | | | Occupancy | | | | | Owner Occupied | 85 | % | | 86 | % | | Investor | 10 | % | | 9 | % | | Secondary | 5 | % | | 5 | % | | Property Type | | | | | Single family | 77 | % | | 78 | % | | Manufactured housing | 3 | % | | 3 | % | | Multi-family/mixed use/other | 20 | % | | 19 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | (dollars in thousands) | | Financial Instrument | | Estimated Fair Value | | Valuation Technique | | Unobservable Input | | Range of Inputs | | Weighted Average | | Derivative assets - IRLCs | | $ | 4,055 | | | Market Pricing | | Pull-through Rate | | 20% - 99% | | 67.3 | % |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | December 31, 2025 | | (dollars in thousands) | | Financial Instrument | | Estimated Fair Value | | Valuation Technique | | Unobservable Input | | Range of Inputs | | Weighted Average | | Derivative assets - IRLCs | | $ | 3,855 | | | Market Pricing | | Pull-through Rate | | 10% - 95% | | 70.0 | % |
|
| Schedule of Financial Assets and Liabilities Carried at Fair Value on a Recurring Basis |
The Company’s financial assets and liabilities carried at fair value on a recurring basis, including the level in the fair value hierarchy, at June 30, 2026 and December 31, 2025 are presented below. | | | | | | | | | | | | | | | | | | | June 30, 2026 | | (dollars in thousands) | | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral, netting | Total | | Assets: | | | | | | | Non-Agency RMBS, at fair value | $ | — | | $ | — | | $ | 727,621 | | $ | — | | $ | 727,621 | | | Agency MBS, at fair value | — | | 5,264,559 | | — | | — | | 5,264,559 | | | Loans held for investment, at fair value | — | | 35,679 | | 7,855,111 | | — | | 7,890,790 | | | Loans held-for-sale, at fair value | — | | 1,126,461 | | — | | — | | 1,126,461 | | | Derivatives, at fair value | 234 | | 114,803 | | 4,055 | | (69,445) | | 49,647 | | | Interests in MSR financing receivables | — | | — | | 35,471 | | — | | 35,471 | | | | | | | | | Liabilities: | | | | | | | Secured financing agreements, at fair value | — | | 283,984 | | — | | — | | 283,984 | | | Securitized debt at fair value, collateralized by Loans held for investment | — | | — | | 5,408,277 | | — | | 5,408,277 | | | Derivatives, at fair value | — | | — | | — | | — | | — | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | December 31, 2025 | | (dollars in thousands) | | Level 1 | Level 2 | Level 3 | Counterparty and Cash Collateral, netting | Total | | Assets: | | | | | | | Non-Agency RMBS, at fair value | $ | — | | $ | — | | $ | 817,280 | | $ | — | | $ | 817,280 | | | Agency MBS, at fair value | — | | 3,463,485 | | — | | — | | 3,463,485 | | | Loans held for investment, at fair value | — | | 75,351 | | 9,728,264 | | — | | 9,803,615 | | | Loans held-for-sale, at fair value | — | | 896,117 | | — | | — | | 896,117 | | | Derivatives, at fair value | 57 | | 25,340 | | 3,855 | | (4,065) | | 25,187 | | | Interests in MSR financing receivables | — | | — | | 37,294 | | — | | 37,294 | | | | | | | | | Liabilities: | | | | | | | Secured financing agreements, at fair value | — | | 298,663 | | — | | — | | 298,663 | | | Securitized debt at fair value, collateralized by Loans held for investment | — | | — | | 6,721,302 | | — | | 6,721,302 | | | Derivatives, at fair value | — | | 1,759 | | — | | — | | 1,759 | | | | | | | |
|
| Summary of the Changes in the Fair Value of Securities Classified as Level 3 |
The table below provides a summary of the changes in the fair value of financial instruments classified as Level 3 at June 30, 2026 and December 31, 2025. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Level 3 Rollforward - Assets | | For the Six Months Ended | | For the Year Ended | | June 30, 2026 | | December 31, 2025 | | (dollars in thousands) | | Non-Agency RMBS | Interests in MSR financing receivables | Loans held for investment | Derivatives | | Non-Agency RMBS | Interests in MSR financing receivables | Loans held for investment | Derivatives | | Beginning balance Level 3 | $ | 817,287 | | $ | 37,294 | | $ | 9,728,264 | | $ | 3,855 | | | $ | 1,064,169 | | $ | — | | $ | 10,858,845 | | $ | — | | | Transfers into Level 3 | — | | — | | — | | — | | | — | | — | | — | | — | | | Transfers out of Level 3 | — | | — | | — | | — | | | — | | — | | — | | — | | | Capital contribution (distribution) | — | | (7,544) | | — | | — | | | — | | 38,221 | | — | | — | | | Purchases of assets | 502 | | — | | 468,012 | | — | | | 1,289 | | — | | — | | 5,073 | | | Principal payments | (50,805) | | — | | (541,565) | | — | | | (92,195) | | — | | (1,198,667) | | — | | | Sales and settlements | (13,491) | | — | | (1,662,592) | | — | | | (165,029) | | — | | (174,471) | | — | | | Servicer advances, net | — | | (2,020) | | — | | — | | | — | | 2,145 | | — | | — | | | Net accretion (amortization) | 13,618 | | — | | (958) | | — | | | 27,792 | | — | | (5,058) | | — | | | Amortization of MSR loan pool | — | | (4,640) | | — | | | | — | | (3,930) | | — | | | | Gains (losses) included in net income | | | | | | | | | | | (Increase) decrease in provision for credit losses | (10,016) | | — | | — | | — | | | (15,705) | | — | | — | | — | | | Realized gains (losses) on sales and settlements | (5,021) | | — | | (35,407) | | — | | | (16,103) | | — | | (18,254) | | — | | | Interest income from investment in MSR financing receivables | — | | 7,789 | | — | | — | | | — | | 4,451 | | — | | — | | | Net unrealized gains (losses) included in income | (6,633) | | 4,592 | | (100,643) | | 200 | | | 26,221 | | (3,592) | | 265,868 | | (1,218) | | | Total unrealized gains (losses) for the period | (17,820) | | — | | — | | — | | | (13,152) | | — | | — | | — | | | Ending balance Level 3 | $ | 727,621 | | $ | 35,471 | | $ | 7,855,111 | | $ | 4,055 | | | $ | 817,287 | | $ | 37,295 | | $ | 9,728,264 | | $ | 3,855 | | | | | | | | | | | | Fair Value Level 3 Rollforward - Liabilities | | For the Six Months Ended | For the Year Ended | | June 30, 2026 | December 31, 2025 | | (dollars in thousands) | | Securitized debt | Securitized debt | | Beginning balance Level 3 | $ | 6,721,302 | | $ | 6,984,495 | | | Transfers into Level 3 | — | | — | | | Transfers out of Level 3 | — | | — | | | Issuance of debt | 378,755 | | 1,011,244 | | | Principal payments | (507,814) | | (1,161,220) | | | Sales and settlements | (1,190,049) | | (382,110) | | | Net (accretion) amortization | 10,321 | | 21,837 | | | (Gains) losses included in net income | | | | Realized (gains) losses on sales and settlements | 41,605 | | (2,142) | | | Net unrealized (gains) losses included in income | (45,843) | | 249,197 | | | Total unrealized (gains) losses for the period | — | | — | | | Ending balance Level 3 | $ | 5,408,277 | | $ | 6,721,302 | |
|
| Schedule of Carrying Value and Fair Value of Financial Instruments Not Carried at Fair Value on a Recurring Basis |
The following table presents the carrying value and fair value, as described above, of the Company’s financial instruments not carried at fair value on a recurring basis at June 30, 2026 and December 31, 2025. | | | | | | | | | | | | | June 30, 2026 | | (dollars in thousands) | | Level in Fair Value Hierarchy | Carrying Amount | Fair Value | Equity method investments (1) | 3 | $ | 70,324 | | $ | 70,324 | | | Secured financing agreements | 2 | 7,441,558 | | 7,482,019 | | | Securitized debt, collateralized by Non-Agency RMBS | 3 | 63,939 | | 44,851 | | | Long term debt | 2 | 252,551 | | 261,912 | | (1) Included in Other assets on the Consolidated Statements of Financial Condition | | | | | | | | | | | | | December 31, 2025 | | (dollars in thousands) | | Level in Fair Value Hierarchy | Carrying Amount | Fair Value | Equity method investments (1) | 3 | $ | 70,191 | | $ | 70,191 | | | Secured financing agreements | 2 | 5,732,519 | | 5,767,481 | | | Securitized debt, collateralized by Non-Agency RMBS | 3 | 66,579 | | 45,172 | | | Long term debt | 2 | 251,528 | | 262,239 | |
(1) Included in Other assets on the Consolidated Statements of Financial Condition
|